LIPELLA PHARMACEUTICALS INC.
LIPONext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for LIPO. That does not mean none is planned.
Get an email about LIPO's next catalysts
Track LIPELLA PHARMACEUTICALS (LIPO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
LP-10 (Liposomal Tacrolimus)
Oral Lichen Planus
LP-10
Hemorrhagic Cystitis
LP-08
Interstitial Cystitis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
LP-10 (Liposomal Tacrolimus) | Phase 2 | Oral Lichen Planus | - | - |
LP-10 | Phase 2 | Hemorrhagic Cystitis | - | - |
LP-08 | Phase 2 | Interstitial Cystitis | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in LIPELLA PHARMACEUTICALS INC.'s drug pipeline?β
CatalystAlert tracks 3 drug candidates in LIPELLA PHARMACEUTICALS INC.'s (LIPO) pipeline across Phase 2. Its lead program is LP-08 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is LIPELLA PHARMACEUTICALS INC.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for LIPELLA PHARMACEUTICALS INC. (LIPO) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track LIPO biotech catalysts?β
Add LIPO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow LIPELLA PHARMACEUTICALS INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
